Search clinical trials for: NTI164

Total 4 results

Fenix Innovation Group
CMAX Clinical Research Pty Ltd; Neurotech International Limited

Active, not recruiting

NTI164 Human PK Study

Healthy | Healthy Volunteer

Australia
Fenix Innovation Group
Neurotech International

Active, not recruiting

Assessing the Safety and Efficacy of Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) in the Treatment of Rett Syndrome (RTT)

Rett Syndrome

Australia
Fenix Innovation Group
Neurotech International

Active, not recruiting

Investigating The Effects Of Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) On Paediatric Acute-onset Neuropsychiatric Syndrome (PANS) (CannaPANS)

PANS Pediatric Acute-Onset Neuropsychiatric Syndrome

Australia
Fenix Innovation Group
Monash Health; Neurotech International

Not yet recruiting

Evaluating the Efficacy of NTI164 in Young People With Autism Spectrum Disorder

Autism Spectrum Disorder

Australia

3

Subscribe